THE ROLE OF PATIENTS AND MEDICAL SPECIALISTS IN ACHIEVING HIGHER LEVEL OF THERAPY COMPLIANCE- AN EXAMPLE WITH WILLINGNESS TO PARTICIPATE IN CLINICAL TRIALS
BACKGROUND: Patients’ compliance is a leading factor in achieving determined endpoints of a treatment process. Low patient compliance with prescribed therapeutic plan is very common in both ambulatory practice and clinical trials. Non-adherence of subjects in clinical studies can seriously jeopardize validity of results obtained during randomized clinical trials (RCTs).
METHODS: Both systematic literature review and cross-sectional survey were conducted among physicians and patients to determine evaluation of therapy adherence by both groups.
RESULTS: According to the analytical reviews in published articles, the most common definition of therapy adherence or compliance is “the ability and willingness of patients to abide to a prescribed therapeutic regimen”. There is a strong correlation between patient adherence to the therapeutic regimen determined by the study protocol of RCTs, and the validity of efficacy and safety evaluation of the investigated medicinal product. Analysis of the results from the conducted survey lead to the conclusion that 35% of physician’s state that the results of ongoing therapy are highly dependent on patient compliance. As far as patients are concerned, almost half of the respondents have answered they comply with the prescribed therapy and would evaluate the treatment process as successful. Both patients and medical professionals declare their willingness to participate in clinical trials and strictly stick to the requirements of the study protocol.Conclusion: These results decisively confirmed that the control of a disease is a bilateral process between the patient and the doctor. Patient satisfaction with their current therapy directly correlates with the results of treatment. Majority of patients evaluate their possible participation in a clinical trial as an opportunity to get an access to a better medical service. Both medical professionals and patients declare their strong motivation to comply with the therapeutic plan if it is a part of a clinical study protocol.
Besch, C. L. (1995). Compliance in clinical trials. Aids, 9(1), 1-10. DOI:10.1097/00002030-199501000-00001
Farmer, K. C. (1999). Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics, 21(6), 1074-1090. DOI:10.1016/s0149-2918(99)80026-5
Haynes, R., & Dantes, R. (1987). Patient compliance and the conduct and interpretation of therapeutic trials. Controlled Clinical Trials, 8(1), 12-19. DOI:10.1016/0197-2456(87)90021-3
Jin, J., Sklar, G. E., Min Sen Oh, V., & Chuen Li, S. (2008). Factors affecting therapeutic compliance: A review from the patient’s perspective. Therapeutics and Clinical Risk Management, 4(1), 269–286.
Pullar, T., Kumar, S., & Feely, M. (1989). Compliance in clinical trials. Annals of the Rheumatic Diseases, 48(10), 871-875. DOI:10.1136/ard.48.10.871
Stenson, N., & Hornby, A. S. (1996). Oxford Advanced Learner's Dictionary of Current English. The Modern Language Journal, 80(3), 412. DOI:10.2307/329464
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (Creative Commons Attribution License 3.0 - CC BY 3.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
email@example.com, www.iseic.cz, ojs.journals.cz